EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer

Zicheng Sun, Huazhen Xu, Guanming Lu, Ciqiu Yang, Xinya Gao, Jing Zhang, Xin Liu, Yongcheng Chen, Kun Wang, Jianping Guo, Jie Li iD

Advanced Science · 2025-05 · 12 (17)

DOI: 10.1002/advs.202408106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.02.2025. Verfasst von Zicheng Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510000, …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Proto-Oncogene Proteins c-akt, Copper, Ferredoxins. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funding Project of Guangzhou, Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a recently defined copper‐dependent cell death pathway, remains largely unexplored in tumor therapies, particularly in breast cancer. This study demonstrates that triple‐negative breast cancer (TNBC) bears a relatively elevated copper levels and exhibits resistance to cuproptosis. Mechanistically, copper activates the AKT signaling pathway, which inhibits ferredoxin‐1 (FDX1), a key regulator of cuproptosis. AKT1‐mediated FDX1 phosphorylation not only abrogates FDX1‐induced cuproptosis and aerobic respiration but also promotes glycolysis. Consequently, the combination of AKT1 inhibitors and the copper ionophores synergistically alleviate TNBC tumorigenesis both in vitro and in vivo. In summary, the findings reveal a crucial mechanism underlying TNBC resistance to cuproptosis and suggest a potential therapeutic approach for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsProto-Oncogene Proteins c-aktCopperFerredoxinsHumansFemaleAnimalsPhosphorylationMiceCell Line, TumorSignal TransductionDrug Resistance, Neoplasm

Stichwörter der Autor:innen

AKT1FDX1breast cancercuproptosismetabolic reprogramming

Substanzen

Proto-Oncogene Proteins c-aktCopperFerredoxinsAKT1 protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510000, China.
  • Department of Breast and Thyroid Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities and Key Laboratory of Molecular Pathology in Tumors of Guangxi, Guangxi, 533000, China.
  • Department of Breast Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, China.
  • Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510000, China.

ORCID-Profile: Jie Li

Förderung

  • National Natural Science Foundation of China
  • Joint Funding Project of Guangzhou
  • Guangxi Natural Science Foundation
  • Affiliated Hospital of Youjiang Medical University for Nationalities
  • ProteomeXchange under the accession
  • Natural Science Foundation of Guangxi Province

Zitieren

APA

Sun, Z., Xu, H., Lu, G., Yang, C., Gao, X., Zhang, J., Liu, X., Chen, Y., Wang, K., Guo, J., & Li, J. (2025). AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer. Advanced Science, 12(17). https://doi.org/10.1002/advs.202408106

Vancouver

Sun Z, Xu H, Lu G, Yang C, Gao X, Zhang J, et al. AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer. Advanced Science. 2025;12(17). doi:10.1002/advs.202408106

BibTeX
@article{Sun2025,
  author = {Sun, Zicheng and Xu, Huazhen and Lu, Guanming and Yang, Ciqiu and Gao, Xinya and Zhang, Jing and Liu, Xin and Chen, Yongcheng and Wang, Kun and Guo, Jianping and Li, Jie},
  title = {AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {17},
  doi = {10.1002/advs.202408106}
}
Kostenlos starten →